Five Crucial Trends Facing U.S. Drug Wholesalers in 2024 and Beyond
The House of Representatives unanimously passed the Seniors’ Access to Critical Medications Act (HR 5526) on Monday, moving the bipartisan bill onto the Senate.1
Hospital consolidation paves the way for uptick in facility fees
The House of Representatives unanimously passed the Seniors’ Access to Critical Medications Act (HR 5526) on Monday, moving the bipartisan bill onto the Senate.1
Medicare’s Proposed Physician Fee Cut Could Lead to Some Hard Decisions
The House of Representatives unanimously passed the Seniors’ Access to Critical Medications Act (HR 5526) on Monday, moving the bipartisan bill onto the Senate.1
Scoop: Medicare pilot aims for $2 generic drugs
The House of Representatives unanimously passed the Seniors’ Access to Critical Medications Act (HR 5526) on Monday, moving the bipartisan bill onto the Senate.1
Many drug price proposals from candidates and Congress won’t have much effect, analysis finds
The House of Representatives unanimously passed the Seniors’ Access to Critical Medications Act (HR 5526) on Monday, moving the bipartisan bill onto the Senate.1
Alternative Approaches to Reducing Prescription Drug Prices
The House of Representatives unanimously passed the Seniors’ Access to Critical Medications Act (HR 5526) on Monday, moving the bipartisan bill onto the Senate.1
Are PDABs Pushing the Limit Drug Pricing Complexities Collide with Implementation
The House of Representatives unanimously passed the Seniors’ Access to Critical Medications Act (HR 5526) on Monday, moving the bipartisan bill onto the Senate.1
Video: Why the FTC’s Lawsuit Against PBMs May Have Some Legs
The House of Representatives unanimously passed the Seniors’ Access to Critical Medications Act (HR 5526) on Monday, moving the bipartisan bill onto the Senate.1
Hospitals face IV shortages driven by hurricane
The House of Representatives unanimously passed the Seniors’ Access to Critical Medications Act (HR 5526) on Monday, moving the bipartisan bill onto the Senate.1
J&J Backs Down From 340B Rebates, But Maintains They’re ‘Legally Permissible’ Per Statute
The House of Representatives unanimously passed the Seniors’ Access to Critical Medications Act (HR 5526) on Monday, moving the bipartisan bill onto the Senate.1
